- Išparduota
/https://libri-media.knygos-static.lt/d30b3c4c-9774-4154-a921-27d126872387/1)
- Leidėjas: Taylor & Francis Ltd.
- Metai: 2013
- Puslapiai: 397
- ISBN: 9781420086362
- ISBN-10: 1420086367
- ISBN-13: 9781420086362
- Formatas: ACSM ?
- Kalba: Anglų
Generic Drug Product Development (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Formatai:
Aprašymas
Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.
Elektroninė knyga:
Atsiuntimas po užsakymo akimirksniu! Skirta skaitymui tik kompiuteryje, planšetėje ar kitame elektroniniame įrenginyje.
Kaip skaityti el. knygas ACSM formatu?
Mažiausia kaina per 30 dienų: 99,99 €
Mažiausia kaina užfiksuota: 2026-06-03 03:20:04
- Leidėjas: Taylor & Francis Ltd.
- Metai: 2013
- Puslapiai: 397
- ISBN: 9781420086362
- ISBN-10: 1420086367
- ISBN-13: 9781420086362
- Formatas: ACSM ?
- Kalba: Anglų
Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.
Atsiliepimai